Product Image

Kyolic Brain Focus

Kyolic
4.6
★ ★ ★ ★ ★
(786 ratings)
Ginkgo
Product Image
Score78
A strong full-serving standardized ginkgo tablet for circulation-focused cognition. Quality disclosure is good but not complete.
How scoring works
Quantity:60 Tablet(s) • (60 servings)
Goals:
Brain Health
Mental Focus
Cognitive Support
Productivity Boost

Score 78

A strong full-serving standardized ginkgo tablet for circulation-focused cognition. Quality disclosure is good but not complete.
How scoring works
$14.99($0.24 per serving)
iHerb
$ 15.71
Pure Formulas
$ 14.99
Vitacost
$ 15.71
Amazon
$ 14.99
iHerb
$ 14.99
Report prices

Analysis

The tablet supplies a full 120 mg of standardized ginkgo extract. Both flavonglycosides and terpene lactones are named, although their percentages and ginkgolic-acid limit are not included.

Ginkgo may support cerebral circulation, memory, and attention, with stronger relevance to sustained use than to an immediate productivity boost. Ocular circulation is a secondary benefit rather than complete vision support.

The focused one-tablet format suits people who want a meaningful ginkgo serving without a large blend. Additional ingredients would be needed for stress, cognitive energy, macular pigment, or retinal nutrition.

Who is it for
  • Adults seeking substantial standardized ginkgo
  • People focused on memory and attention
  • Users who prefer a single daily tablet
Best for
  • Sustained cognitive-support routines
  • Cerebral-circulation support
  • Focused single-ingredient use

Pros

  • Provides a full extract amount
  • Names both key marker classes
  • Simple one-tablet formulation

Cons

  • Marker percentages are absent
  • No ginkgolic-acid purity limit
  • Does not cover broader cognitive or vision pathways

Warnings

  • Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines.
  • Bleeding risk around surgery should be discussed with the care team.
  • Headache, dizziness, or digestive discomfort may occur.

Nutrient quality

83 Highest impact

The key ginkgo marker groups are named, but their percentages and a purity limit are not fully disclosed. The formula supplies a full target-range extract amount, with no obvious overdosing.

.

Ingredient transparency

80 High impact

The main active amounts are clearly listed, and no proprietary blend hides them. Intake directions, non-active ingredients, and some extract-quality details are absent from the supplied data.

.

Customer satisfaction

66 High impact

The supplied average is positive but less compelling and the response volume is moderate. No detailed feedback is provided to assess recurring complaints or fit with the intended purpose.

.

Value for money

80 Highest impact

The serving cost is appealing, but incomplete extract verification limits confidence in value. A fully standardized extract would provide a more dependable comparison.

.
Report analysis

Goals

Brain Health
Brain Health
Impact
Highest effect
A- Goal FitA- Strength of SupportC- CoverageA+ Formula Quality

Ginkgo directly targets cerebral circulation and has relevant human evidence for cognitive support. The disclosed extract amount is well aligned with common clinical use.

Both major ginkgo marker groups are named, but their percentages and a ginkgolic-acid limit are missing. Ginkgo may raise bleeding risk with anticoagulant or antiplatelet drugs, so concurrent use needs specific medical review.

Study evidence
Ginkgo Supportive 90 studies
Mental Focus
Mental Focus
Impact
Highest effect
B Goal FitA- Strength of SupportC CoverageA Formula Quality

A standardized ginkgo extract provides a plausible cerebral-blood-flow pathway for attention and processing speed. Human findings are mixed in healthy adults and appear more useful in older people or those with cognitive concerns.

The serving amount matches common studied use, and the main marker groups are identified. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines, making that interaction important before regular use.

Study evidence
Ginkgo Supportive 28 studies
Cognitive Support
Cognitive Support
Impact
High effect
B Goal FitA Strength of SupportD CoverageA Formula Quality

Ginkgo may support cerebral blood flow and selected aspects of memory, giving it a direct cognitive mechanism. The 120 mg extract amount is disclosed with flavonglycoside and terpene-lactone markers.

Evidence is mixed for cognitive enhancement in healthy adults and is more relevant to age-related decline or circulation-related needs. Ginkgo can increase bleeding risk with anticoagulant or antiplatelet medicines and around surgery.

Study evidence
Ginkgo Supportive 87 studies
Productivity Boost
Productivity Boost
Impact
High effect
B Goal FitB+ Strength of SupportC- CoverageA Formula Quality

A 120 mg ginkgo extract offers a clear cognitive and circulation-oriented strategy. Active-marker groups are named, but missing percentages and ginkgolic-acid limits leave standardization incomplete.

Human evidence is more consistent for cognitive impairment than for immediate enhancement in healthy adults. Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines, so that combination requires clinician review.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Vision Support
Vision Support
Impact
Moderate effect
D Goal FitB- Strength of SupportD- CoverageB- Formula Quality

Ginkgo may support ocular blood flow in specific vascular situations, but it is not broad vision support. Evidence for meaningful visual outcomes remains more limited than for macular carotenoids or established antioxidant combinations.

The standardized extract reaches a commonly used serving, though marker percentages and a purity limit are not disclosed. Ginkgo can increase bleeding risk with anticoagulant or antiplatelet medicines, so that combination deserves specific medical review.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Ginkgo biloba standardized extract (Ginkgo Flavonglycosides, Terpene Lactones)
 120 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free Vegetarian
Report overview
Ginkgo (Ginkgo Flavonglycosides, Terpene Lactones) · 120 mg OverallScore66
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The full clinical extract amount is clear and comes at a low serving cost. Both main active-marker groups are named, but their percentages and a ginkgolic-acid purity guarantee are absent. Ginkgo may raise bleeding risk with anticoagulants or antiplatelet drugs, so concurrent use requires specific medical review.

View ingredientView products
Loading alternative details
83 Performance

Ginkgold 120 mg

Nature's Way
A 120 mg Ginkgold extract identified by flavone glycosides and terpene lactones offers a focused, substantial ginkgo dose. Exact marker percentages and a ginkgolic-acid limit are not supplied, so extract characterization is still incomplete.
84 Performance

Ginkgo Biloba Phytosome 60 mg

Natural Factors HerbalFactors
A 60 mg Ginkgoselect phytosome uses a distinct delivery format that may suit someone prioritizing a compact dose. The supplied label does not state flavone, terpene, or ginkgolic-acid details, which limits direct potency comparison.
84 Performance

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
A concise 120 mg extract identified by flavone glycosides and terpene lactones provides stronger dose depth than many 40 mg or 60 mg formulas. Marker percentages and a ginkgolic-acid limit are not shown, but the simple formula supports clear comparison.
83 Budget

Ginkgo Biloba 60 mg

NOW
A lower recurring cost provides a 60 mg extract identified by ginkgo flavone glycosides and terpene lactones plus 200 mg of ginkgo powder. Marker percentages are not stated, but the added powder and long supply provide useful depth for the cost.
84 Budget

Ginkgo Biloba Certified Extract 120 mg

Life Extension
A lower recurring cost provides 120 mg of ginkgo with flavone glycosides, terpene lactones, and a stated low ginkgolic-acid limit. Exact marker percentages are not shown, while the impurity limit and long supply improve practical quality.
83 Budget

Ginkgo Biloba 60 mg

Swanson Superior Herbs
A lower recurring cost provides a branded 60 mg GinkgoSelect extract identified by flavone glycosides and terpene lactones. The marker percentages are missing, but the focused formula remains easy to assess and inexpensive to use.
84 Value

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
A lower serving cost than the original accompanies the following trade-off: a 120 mg ginkgo extract identified by flavone glycosides and terpene lactones combines a substantial dose with a long supply. The missing marker percentages and ginkgolic-acid limit are the main quality gaps.
80 Value

Double Strength Ginkgo Biloba 120 mg

NOW
A lower serving cost than the original accompanies the following trade-off: a 120 mg ginkgo extract identified by flavone glycosides and terpene lactones is paired with 250 mg of eleuthero at a low serving cost. Exact ginkgo marker percentages are absent, and eleuthero makes the formula less focused than a single-ingredient option.
80 Value

Ginkgo-24 120 mg

Source Naturals
A lower serving cost than the original accompanies the following trade-off: a simple 120 mg ginkgo extract identifies both flavone glycosides and terpene lactones at a moderate serving cost. The label does not state exact marker percentages or a ginkgolic-acid limit.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  2. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  3. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support Productivity Boost forGinkgo
  4. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  5. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  6. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  7. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledProductivity Boost Brain Health forGinkgo
  8. Effects of Ginkgo biloba on alertness and chemosensory function in healthy adults.
    Mattes RD; Pawlik MK · Human psychopharmacology · 2004
    Randomized trial39 participantsProductivity Boost forGinkgo
  9. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  10. Ginkgo biloba--an appraisal.
    Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY · Kathmandu University medical journal (KUMJ) · 2007
    Narrative reviewVision Support forGinkgo
  11. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  12. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  13. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  14. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  15. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  16. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  17. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  18. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  19. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  20. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  21. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  22. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  23. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  24. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  25. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  26. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  27. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  28. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  29. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  30. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  31. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  32. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo